DK0812589T3 - Kombineret antipyretisk og analgetisk lægemiddel - Google Patents

Kombineret antipyretisk og analgetisk lægemiddel

Info

Publication number
DK0812589T3
DK0812589T3 DK95902295T DK95902295T DK0812589T3 DK 0812589 T3 DK0812589 T3 DK 0812589T3 DK 95902295 T DK95902295 T DK 95902295T DK 95902295 T DK95902295 T DK 95902295T DK 0812589 T3 DK0812589 T3 DK 0812589T3
Authority
DK
Denmark
Prior art keywords
isopropylantipyrine
combined
layer containing
antipyretic
analgesic drug
Prior art date
Application number
DK95902295T
Other languages
Danish (da)
English (en)
Inventor
Takashi Fujitsu
Kikuko Yoneda
Isao Ikebe
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26416787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0812589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0812589T3 publication Critical patent/DK0812589T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95902295T 1993-12-10 1994-12-02 Kombineret antipyretisk og analgetisk lægemiddel DK0812589T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31080393 1993-12-10
JP7563894 1994-04-14
PCT/JP1994/002031 WO1995015751A1 (en) 1993-12-10 1994-12-02 Combined antipyretic analgesic drug

Publications (1)

Publication Number Publication Date
DK0812589T3 true DK0812589T3 (da) 2000-11-13

Family

ID=26416787

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95902295T DK0812589T3 (da) 1993-12-10 1994-12-02 Kombineret antipyretisk og analgetisk lægemiddel

Country Status (13)

Country Link
US (1) US5686109A (https=)
EP (1) EP0812589B1 (https=)
JP (1) JP3168582B2 (https=)
KR (1) KR100347631B1 (https=)
CN (1) CN1094756C (https=)
AT (1) ATE195418T1 (https=)
DE (1) DE69425589T2 (https=)
DK (1) DK0812589T3 (https=)
ES (1) ES2148470T3 (https=)
GR (1) GR3034434T3 (https=)
PT (1) PT812589E (https=)
TW (1) TW279799B (https=)
WO (1) WO1995015751A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US6812985B1 (en) 1996-09-23 2004-11-02 Lg.Philips Lcd Co., Ltd. Liquid crystal display device
KR100251512B1 (ko) 1997-07-12 2000-04-15 구본준 횡전계방식 액정표시장치
JP4828707B2 (ja) * 2000-02-28 2011-11-30 武田薬品工業株式会社 固形圧縮製剤
ES2265022T3 (es) * 2001-03-14 2007-02-01 Pfizer Products Inc. Comprimido farmaceutico y procedimiento para su fabricacion.
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JP2003095944A (ja) * 2001-09-27 2003-04-03 Kowa Co 鎮痛剤
US8263126B2 (en) * 2003-06-06 2012-09-11 Ethypharm Orally-dispersible multilayer tablet
FR2855756B1 (fr) * 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
AU2005245025B2 (en) * 2004-05-21 2010-06-03 Accu-Break Technologies, Inc. Pharmaceutical tablets comprising two or more unitary segments
EP1948138A4 (en) * 2005-11-18 2012-07-11 Accu Break Technologies Inc SEGMENTED PHARMACEUTICAL DOSAGE FORMS
EP2034953A4 (en) * 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
WO2008021875A2 (en) * 2006-08-08 2008-02-21 Accu-Break Technologies, Inc. Pharmaceutical tablets containing a plurality of active segments
EP2070520A1 (en) * 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
JP2013121948A (ja) * 2011-11-07 2013-06-20 Daiichi Sankyo Healthcare Co Ltd 眠気が改善された感冒薬
JP6307874B2 (ja) * 2012-12-27 2018-04-11 大正製薬株式会社 レイヤリング粒子
JP7419057B2 (ja) * 2019-12-27 2024-01-22 ライオン株式会社 錠剤及びコーティング錠

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609752B2 (ja) * 1979-11-09 1985-03-12 東邦新薬株式会社 新規な2−アセトキシベンズアミド誘導体、その製法及びそれを有効成分とする医薬
JPS5697224A (en) * 1979-12-28 1981-08-05 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPS61134315A (ja) * 1984-12-05 1986-06-21 Taisho Pharmaceut Co Ltd 解熱鎮痛剤
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
EP0497977B1 (en) * 1989-10-26 1995-03-15 Nippon Shinyaku Company, Limited Gastric preparation
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US5498422A (en) * 1991-04-08 1996-03-12 Nippon Shinyaku Company Limited Sustained release capsule
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof

Also Published As

Publication number Publication date
CN1142766A (zh) 1997-02-12
KR960706335A (ko) 1996-12-09
EP0812589A1 (en) 1997-12-17
ES2148470T3 (es) 2000-10-16
CN1094756C (zh) 2002-11-27
EP0812589B1 (en) 2000-08-16
PT812589E (pt) 2000-11-30
WO1995015751A1 (en) 1995-06-15
TW279799B (https=) 1996-07-01
GR3034434T3 (en) 2000-12-29
EP0812589A4 (en) 1999-06-23
JP3168582B2 (ja) 2001-05-21
US5686109A (en) 1997-11-11
DE69425589T2 (de) 2001-01-04
ATE195418T1 (de) 2000-09-15
KR100347631B1 (ko) 2002-11-29
DE69425589D1 (de) 2000-09-21

Similar Documents

Publication Publication Date Title
DK0812589T3 (da) Kombineret antipyretisk og analgetisk lægemiddel
SE9600070D0 (sv) New oral pharmaceutical dosage forms
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
AR242711A1 (es) Pelicula laminada bicomponente, el proceso para obtenerla y el articulo absorbente desechable que la incluye.
IT1255522B (it) Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1282576B1 (it) Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
CA2182508A1 (en) Abuse resistant tablets
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
DE3878889D1 (de) Packung und verpackung mit sauerstoff absorbierenden mitteln.
DE3567025D1 (en) Polymerisable compounds with perfluoroalkyl groups, registration layers containing them and their use in dry lithography
ES2170223T3 (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
MX9202891A (es) Laminado de barrera al oxigeno y al sabor que incluyen nylon amorfos.
EP0648101A4 (en) ABSORBENT STRUCTURE FROM SEVERAL LAYERS.
DE3680741D1 (de) Hydraulisches spielausgleichselement mit kombinierter vorratsraumerweiterung und zumessvorrichtung.
RU93004786A (ru) Платформа
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
FI91502B (fi) Diagonaalinen viilukerrospuu
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
DE68917417D1 (de) Feine Bereiche aufweisende Verbundfolien aus Polyimid-Mischungen.
DE3581006D1 (de) Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung.
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai
KR920019369A (ko) 위장병에 유용한 제약학적 복합 성분물
TH24054A (th) ผลิตภัณฑ์กระดาษแผ่นเยื่อที่มีสารยา
JPH0184648U (https=)